NEGX
COM:NEXGENRX
NexgenRx
- Stock
Last Close
0.20
18/11 20:00
Market Cap
13.48M
Beta: -
Volume Today
2.50K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 0.50 - | 0.00 100.00% | 0.00 50% | 1 107,374,182,300% | ||
average payables | 791.93K - | 903.74K 14.12% | 899.16K 0.51% | 786.20K 12.56% | ||
average receivables | 260.11K - | 328.66K 26.36% | 340.72K 3.67% | 444.64K 30.50% | ||
book value per share | 0.02 - | 0.06 205.32% | 0.10 65.53% | 0.09 9.53% | 0.08 11.10% | |
capex per share | -0.01 - | -0.01 14.63% | -0.01 19.61% | -0.01 63.28% | -0.00 49.99% | |
capex to depreciation | -1.15 - | -1.15 0.09% | -1.03 10.79% | -0.36 64.87% | -0.19 47.29% | |
capex to operating cash flow | 0.61 - | 1.17 90.97% | -0.46 139.03% | -0.15 67.42% | 0.07 146.29% | |
capex to revenue | -0.10 - | -0.10 1.06% | -0.12 12.08% | -0.04 65.33% | -0.02 53.60% | |
cash per share | 0.15 - | 0.20 29.76% | 0.21 6.48% | 0.18 14.90% | 0.24 31.38% | |
days of inventory on hand | 0.00 - | 0.00 100.00% | 0.00 31.73% | 0.00 - | ||
days payables outstanding | 210.93 - | 138.63 34.28% | 153.50 10.73% | 84.06 45.24% | 99.59 18.47% | |
days sales outstanding | 12.27 - | 12.46 1.61% | 14.84 19.05% | 11.91 19.73% | 21.36 79.34% | |
debt to assets | 0.16 - | 0.06 63.99% | 0.02 74.04% | 0.02 45.99% | 0.02 11.51% | |
debt to equity | 1.87 - | 0.27 85.70% | 0.05 82.79% | 0.06 40.13% | 0.08 19.07% | |
dividend yield | 0.00 - | 0.00 6.56% | 0.05 1,067.77% | 0.05 14.39% | ||
earnings yield | -0.01 - | 0.12 1,297.98% | 0.12 0.08% | -0.00 100.94% | -0.02 1,593.33% | |
enterprise value | 7.90M - | 539.74K 93.16% | 10.11M 1,772.29% | 1.77M 82.53% | -3.75M 312.37% | |
enterprise value over ebitda | 14.37 - | 0.28 98.05% | 3.67 1,207.19% | 1.61 56.14% | -8.22 610.20% | |
ev to operating cash flow | -6.57 - | -0.75 88.61% | 4.27 670.76% | 0.70 83.51% | 1.38 96.02% | |
ev to sales | 1.10 - | 0.07 93.97% | 1.08 1,539.07% | 0.19 82.45% | -0.37 296.49% | |
free cash flow per share | -0.03 - | -0.02 19.20% | 0.02 176.53% | 0.03 76.82% | -0.04 235.72% | |
free cash flow yield | -0.12 - | -0.12 6.54% | 0.05 142.86% | 0.15 201.06% | -0.23 252.05% | |
graham net net | -0.06 - | -0.02 67.95% | 0.01 148.30% | 0.01 13.60% | 0.00 43.78% | |
graham number | 0.03 - | 0.18 462.33% | 0.31 72.00% | 0.02 92.92% | 0.08 266.58% | |
income quality | 7.50 - | -0.43 105.80% | 0.75 271.50% | -151.73 20,465.36% | 10.85 107.15% | |
intangibles to total assets | 0.36 - | 0.31 13.20% | 0.27 11.76% | 0.28 2.90% | 0.19 31.47% | |
interest coverage | -0.32 - | 4.34 1,448.79% | 11.32 161.16% | 0.52 95.38% | -18.33 3,605.06% | |
interest debt per share | 0.04 - | 0.02 51.35% | 0.01 67.19% | 0.01 12.95% | 0.01 11.13% | |
inventory turnover | 1.55M - | 974.49T 62,959,587,540.98% | 1427.34T 46.47% | 1.63M - | ||
invested capital | 1.87 - | 0.27 85.70% | 0.05 82.79% | 0.06 40.13% | 0.08 19.07% | |
market cap | 15.58M - | 13.47M 13.55% | 25.75M 91.12% | 14.21M 44.80% | 12.72M 10.49% | |
net current asset value | -3.79M - | -1.06M 72.06% | 875.63K 182.70% | 817.55K 6.63% | 648.83K 20.64% | |
net debt to ebitda | -14.00 - | -6.73 51.89% | -5.69 15.54% | -11.36 99.74% | -36.11 217.91% | |
net income per share | -0.00 - | 0.02 1,135.67% | 0.04 78.71% | -0.00 100.55% | -0.00 1,411.51% | |
operating cash flow per share | -0.02 - | -0.01 39.98% | 0.03 406.48% | 0.04 12.72% | -0.04 208.04% | |
payables turnover | 1.73 - | 2.63 52.16% | 2.38 9.69% | 4.34 82.60% | 3.66 15.59% | |
receivables turnover | 29.76 - | 29.29 1.58% | 24.60 16.00% | 30.65 24.58% | 17.09 44.24% | |
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.02 - | 0.12 895.97% | 0.19 54.71% | -0.00 100.64% | -0.01 1,025.15% | |
revenue per share | 0.10 - | 0.12 13.43% | 0.12 6.72% | 0.13 5.91% | 0.14 7.78% | |
roe | -0.11 - | 0.38 439.21% | 0.41 7.96% | -0.00 100.61% | -0.04 1,600.17% | |
roic | -0.02 - | 0.24 1,670.48% | 0.41 74.03% | -0.00 100.33% | -0.09 6,356.47% | |
sales general and administrative to revenue | 0.06 - | 0.06 2.09% | 0.07 11.29% | 0.07 4.77% | ||
shareholders equity per share | 0.02 - | 0.06 205.32% | 0.10 65.53% | 0.09 9.53% | 0.08 11.10% | |
stock based compensation to revenue | 0.02 - | 0.01 58.96% | 0.01 13.92% | 0.01 39.77% | 0.00 46.63% | |
tangible asset value | -4.41M - | -1.80M 59.18% | 1.32M 173.44% | 1.19M 9.92% | 1.43M 20.26% | |
tangible book value per share | -0.06 - | -0.02 62.84% | 0.02 196.40% | 0.02 1.99% | 0.02 14.22% | |
working capital | -2.61M - | -489.10K 81.25% | 1.01M 306.83% | 1.11M 9.27% | 952.51K 13.83% |
All numbers in USD (except ratios and percentages)